EDSIVO Trademark

Trademark Overview

On Tuesday, March 7, 2017, a trademark application was filed for EDSIVO with the United States Patent and Trademark Office. The USPTO has given the EDSIVO trademark a serial number of 87361176. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 12, 2020. This trademark is owned by Acer Therapeutics Inc.. The EDSIVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of genetic connective tissue disorders
edsivo

General Information

Serial Number87361176
Word MarkEDSIVO
Filing DateTuesday, March 7, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 12, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2017

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of genetic connective tissue disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 11, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameACER THERAPEUTICS INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEWTON, MA 02458
Party NameAcer Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAcer Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, October 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 12, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 6, 2020EXTENSION 5 GRANTED
Tuesday, February 25, 2020EXTENSION 5 FILED
Friday, March 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 25, 2020TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 30, 2019EXTENSION 4 GRANTED
Friday, August 30, 2019EXTENSION 4 FILED
Friday, August 30, 2019TEAS EXTENSION RECEIVED
Wednesday, August 28, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 28, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 27, 2019EXTENSION 3 GRANTED
Wednesday, February 27, 2019EXTENSION 3 FILED
Wednesday, February 27, 2019TEAS EXTENSION RECEIVED
Saturday, August 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 16, 2018EXTENSION 2 GRANTED
Thursday, August 16, 2018EXTENSION 2 FILED
Thursday, August 16, 2018TEAS EXTENSION RECEIVED
Wednesday, August 8, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, March 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2018EXTENSION 1 GRANTED
Tuesday, February 27, 2018EXTENSION 1 FILED
Tuesday, February 27, 2018TEAS EXTENSION RECEIVED
Tuesday, September 5, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 1, 2017ASSIGNED TO EXAMINER
Saturday, March 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

edsivo tissue disorders connective genetic products treatment pharmaceutical